scispace - formally typeset
P

Pablo Garcia

Researcher at Stanford University

Publications -  51
Citations -  731

Pablo Garcia is an academic researcher from Stanford University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 11, co-authored 43 publications receiving 388 citations. Previous affiliations of Pablo Garcia include Saint Peter's University Hospital.

Papers
More filters
Journal ArticleDOI

Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.

TL;DR: In this paper, the authors used Poisson regression to evaluate risk factors for absent or attenuated response to vaccination, and found that 22% of patients receiving dialysis had suboptimal responses to vaccination irrespective of whether they had evidence of prior SARS-CoV-2 infection.
Journal ArticleDOI

Acute kidney injury in patients treated with immune checkpoint inhibitors.

Shruti Gupta, +67 more
TL;DR: In this paper, a multivariable logistic regression model was used to identify predictors of ICPi-AKI and its recovery, and the effect of rechallenge versus no re-challenge on survival was estimated.
Journal ArticleDOI

Trends of Cannabis Use Disorder in the Inpatient: 2002 to 2011

TL;DR: Cannabis abuse/dependence is on the rise in the inpatient population, with an increasing trend toward older and sicker patients with increasing rates of moderate to severe disability.
Patent

Method and apparatus for electrostatic dispensing of microdroplets

TL;DR: In this paper, an apparatus and device for dispensing femtoliter to nanoliter volumes of liquid samples is described, which includes a liquid support plate, two electrodes, a substrate, and a control unit.
Posted ContentDOI

Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis

TL;DR: In this paper, the authors used Poisson regression to evaluate risk factors for absent or attenuated response to vaccination, and found that 22% of patients receiving dialysis had suboptimal responses to vaccination irrespective of whether they had evidence of prior SARS-CoV-2 infection.